C Warren Olanow1, O Rascol. Show Affiliations » 1. Department of Neurology, Mount Sinai School of Medicine, New York, NY 10029, USA. Warren.olanow@mssm.edu
Abstract
Entities: Disease
Mesh: See more » Data Interpretation, StatisticalDose-Response Relationship, DrugEndpoint DeterminationHumansIndans/administration & dosageNeuroprotective Agents/administration & dosageOutcome Assessment, Health Care/methodsParkinson Disease/drug therapyParkinson Disease/physiopathologyRandomized Controlled Trials as Topic/methodsRandomized Controlled Trials as Topic/standardsReproducibility of ResultsResearch Design/standardsRisk AssessmentTime FactorsTreatment Outcome
Substances: See more » IndansNeuroprotective Agentsrasagiline
Year: 2010 PMID: 20368635 DOI: 10.1212/WNL.0b013e3181d7d94b
Source DB: PubMed Journal: Neurology ISSN: 0028-3878 Impact factor: 9.910